Spinal Elements Holdings, Inc. (SPEL)
| Market Cap | 386.20M |
| Revenue (ttm) | 92.56M |
| Net Income (ttm) | -48.09M |
| Shares Out | 27.59M |
| EPS (ttm) | -1.74 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | n/a |
| Last Price | n/a |
| Previous Close | n/a |
| Change ($) | n/a |
| Change (%) | n/a |
| Day's Open | n/a |
| Day's Range | n/a |
| Day's Volume | n/a |
| 52-Week Range | n/a |
CARLSBAD, Calif.--(BUSINESS WIRE)--Spinal Elements® Announces the Acquisition of Benvenue Medical Assets
CARLSBAD, Calif.--(BUSINESS WIRE)--Spinal Elements® Announces First Procedure with Sapphire X™ Anterior Cervical Fixation System
CARLSBAD, Calif.--(BUSINESS WIRE)--Spinal Elements® Announces the Expansion of its MIS Ultra™ Offering with the Full Market Release of the Lucent® XP Wide Expandable Device
Nine IPOs and five SPACs went public this past week, and one IPO postponed.
Spinal Elements Holdings has filed an amended S-1 form with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering.
Spinal Elements Holdings Inc. has set terms of its initial public offering on Thursday, as the California-based spinal surgery device maker looks to raise up to $115.5 million.
About SPEL
Spinal Elements is a medical device company focused on the design, development and commercialization of a comprehensive portfolio of systems, products and technologies for spine surgery procedures, with a strategic focus on minimally invasive surgery (“MIS”) procedures. We are an innovation-driven company with a track-record of delivering pioneering and differentiated products and technologies. Our product portfolio addresses a broad spectrum of spine surgery procedures and consists of innovative spinal fixation systems (implantable hardwar... [Read more...]
| Industry Health Care / Medical Devices | IPO Date Postponed |
| CEO Jason Blain | Employees 120 |
| Stock Exchange NASDAQ | Ticker Symbol SPEL |